SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neopath (NPTH) -- Ignore unavailable to you. Want to Upgrade?


To: Kerry Lee who wrote (111)1/28/1998 6:56:00 PM
From: Jim Armstrong  Respond to of 178
 
Apparently just specifics regarding labelling. They're through the FDA panel wicket. JimA



To: Kerry Lee who wrote (111)1/28/1998 7:46:00 PM
From: Jim Armstrong  Read Replies (1) | Respond to of 178
 
Wall Street Journal says that the system's labeling
should specify that the clinical data didn't include explicit
study of "high-risk" patient groups in its clinical studies,
according to NeoPath Chief Executive Alan Nelson. JimA